Non-hemic autoimmunity in CLL

Leukemia Research

Volumn 33, Issue 3, 2009, Pages 366-367

  Hamblin, Terry J ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Autoimmunity; CLL; Fludarabine; Glomerulonephritis; Neurological syndrome; Paraneoplastic; Paraneoplastic pemphigus

Indexed keywords

CYCLOPHOSPHAMIDE; FLUDARABINE; IMMUNOGLOBULIN; MITOXANTRONE; PREDNISOLONE; RITUXIMAB;

ANGIONEUROTIC EDEMA; AUTOIMMUNE DISEASE; AUTOIMMUNE HEMOLYTIC ANEMIA; AUTOIMMUNE THROMBOCYTOPENIA; AUTOIMMUNITY; BRAIN DAMAGE; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM; CHRONIC LYMPHATIC LEUKEMIA; COMA; DIZZINESS; EDITORIAL; EPILEPTIC STATE; GLOMERULONEPHRITIS; HERPES ZOSTER; HUMAN; IMMUNE RESPONSE; INCIDENCE; LIMB WEAKNESS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC PEMPHIGUS; PARIETAL LOBE; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; REGULATORY T LYMPHOCYTE;

ANGIOEDEMA; AUTOIMMUNITY; GLOMERULONEPHRITIS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; PEMPHIGUS;

EID: 58549095039     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2008.09.011     Document Type: Editorial

References (23)

1. Hamblin T.J., Oscier D.G., and Young B.J. Autoimmunity in chronic lymphocytic leukaemia. J Clin Pathol 39 (1986) 713-716
2. Hamblin T.J. Autoimmune complications of chronic lymphocytic leukemia. Sem Oncol 33 (2006) 230-239
3. Barker R.N., Hall A.M., Standen G.R., Jones J., and Elson C.J. Identification of T-cell epitopes on the Rhesus polypeptides in autoimmune hemolytic anemia. Blood 90 (1997) 2701-2715
4. Hall A.M., Vickers M.A., McLeod E., and Barker R.N. Rh autoantigen presentation to helper T cells in chronic lymphocytic leukemia by malignant B cells. Blood 105 (2005) 2007-2015
5. Hamblin T.J. Autoimmune disease and its management in chronic lymphocytic leukemia. In: Cheson B.D. (Ed). Chronic Lymphoid Leukemias. 2nd ed. (2001), Marcel Dekker, New York 435-458
6. Myint H., Copplestone J.A., Orchard J., et al. Fludarabine-related AIHA in patients with chronic lymphocytic leukaemia. Br J Haematol 91 (1995) 341-344
7. hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine. Blood 106 (2005) 2018-2025
8. Shevak E.M. Regulatory T cells in autoimmunity. Ann Rev Immunol 18 (2000) 423-449
9. Giannopoulos K., Schmitt M., Kowal M., et al. Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia. Oncol Rep 20 (2008) 677-682
10. Hus J., Schmitt M., Tabarkiewicz J., et al. Vaccination of B-CLL patients with autologous dendritic cells can change the frequency of leukemia antigen-specific CD8+ T cells as well as CD4+CD25+FocP3+ regulatory T cells toward an antileukemia response. Leukemia 22 (2008) 1007-1017
11. Bazarbachi A., Bachelez H., Dehen L., Delmer A., Zittoun R., and Dubertret L. Lethal paraneoplastic pemphigus following treatment of chronic lymphocytic leukaemia with fludarabine. Ann Oncol 6 (1995) 730-731
12. Braess J., Reich K., Willert S., Strutz F., Neumann C., Hiddemann W., and Wormann B. Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL). Ann Hematol 75 (1997) 227-230
13. Gooplu C., Littlewood T.J., Frith P., et al. Paraneoplastic pemphigus-an association with fludarabine. Br J Dermatol 144 (2001) 1102-1104
14. Powell A.M., Albert S., Oyama N., Sakuma-Oyama Y., Bhogal B., and Black M.M. Paraneoplastic pemphigus secondary to fludarabine evolving into unusual oral pemphigus vegetans. J Eur Acad Dermatol Venereol 18 (2004) 360-364
15. Yildiz O., Ozguroglu M., Yanmaz M.T., et al. Paraneoplastic pemphigus associated with fludarabine use. Med Oncol 24 (2007) 115-118
16. Macheta M.P., Parapia L.A., and Gouldesbrough D.R. Renal failure in a patient with chronic lymphocytic leukaemia treated with fludarabine. J Clin Pathol 48 (1995) 181-182
17. Tisler A., Pierratos A., and Lipton J.H. Crescentic glomerulonephritis with p-ANCA positivity in fludarabine-treated chronic lymphocytic leukaemia. Nephrol Dial Transplant 11 (1996) 2306-2308
18. Qian S.X., Li J.Y., Hong M., Xu W., and Qiu H.X. Nonhematological autoimmunity (glomerulosclerosis, paraneoplastic pehigus and paraneoplastic neurological syndrome) in a patient with chronic lymphocytic leukemia: diagnosis, prognosis and management. Leuk Res (2008)
19. Graus F., Delattre J.Y., Antoine J.C., et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 75 (2004) 1135-1140
20. Bojsen-Mǿller M., and Nielsen J.L. CNS involvement in leukaemia. An autopsy study of 100 consecutive patients. Acta Pathol Microbiol Immunol Scand A 91 (1983) 209-216
21. Shafran B., Roke M.E., Barr R.M., and Caircross J.G. Contrast enhancing lesions in progressive multifocal leukoencephalopathy: a clinicopathological correlation. Can J Neurol Sci 14 (1987) 600-602
22. Cid J., Revilla M., Cervera A., et al. Progressive multifocal leukoencephalopathy following oral fludarabine treatment of chronic lymphocytic leukemia. Ann Hematol 79 (2000) 392-395
23. Saumoy M., Castells G., Escoda L., Mares R., Richart C., and Ugarriza A. Progressive multifocal leukoencephalopathy in chronic lymphocytic leukemia after treatment with fludarabine. Leuk Lymphoma 43 (2002) 433-436